This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
Bunzl PLC | 3,456.7 | 7.6% |
Easyjet PLC | 477.6 | 6.6% |
Anglo American PLC | 2,288.0 | 1.7% |
Antofagasta PLC | 1,908.5 | 1.6% |
Whitbread PLC | 2,894.0 | 1.6% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
Barratt Developments PLC | 519.6 | -5.8% |
Scottish Mortgage Investment Trust PLC | 822.1 | -4.8% |
Berkeley Group Holdings (The) PLC | 4986.0 | -4.2% |
Jd Sports Fashion PLC | 143.2 | -4.1% |
Persimmon PLC | 1640.5 | -3.8% |
Major World Indices | Price | % Chg | 1 Year |
UK 100 INDEX | 8,345 | 0.2% | 13.7% |
DOW JONES INDUS. AVG | 41,251 | 0.0% | 19.4% |
DAX INDEX | 18,682 | 0.4% | 18.3% |
NIKKEI 225 | 38,372 | 0.2% | 19.3% |
S&P/ASX 200 INDEX | 8,071 | 0.0% | 12.7% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 75.65 | 0.16% |
Brent Crude (ICE) | USD/bbl. | 79.68 | 0.16% |
Gold Spot | USD/t oz. | 2,507 | -0.7% |
Copper (Comex) | USd/lb. | 426 | -1.0% |
The UK 100 called to open +30 points at 8,375. The UK 100 looks set to open higher again this morning.
Stateside yesterday saw the S&P rise slightly on Tuesday as investors looked ahead to a major earnings report later this week. The broad market index gained 0.16% to close at 5,625.80, while the Nasdaq crept 0.16% higher to end at 17,754.82. The Dow Jones rose 9.98 points, or 0.02%, to end at 41,250.50, its second record close in a row.
Focus will today be on earnings released from top artificial intelligence beneficiary Nvidia, due after Wednesday’s closing bell.
Markets in Asia this morning traded broadly lower today, in Japan the Nikkei 225 Index closed the morning session at 38,199.52, down 89.10 points or 0.23 percent, after hitting a low of 38,141.49 earlier. Elsewhere in Asia, New Zealand, China, Hong Kong, Singapore, South Korea and Taiwan were lower by between 0.1% and 1.0% each.
Delaware’s highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
Prudential raised its first interim dividend by 9.3% despite a 66% fall in IFRS attributable pretax profit to $394 million in the first half of 2024 from USD1.18 billion a year before. Adjusted operating profit was $1.54 billion, up 6% from $1.46 billion. New business profit was down 1% to $1.47 billion from $1.49 billion, but the Asia-focused insurer and asset manager said it saw a pick-up in sales momentum in June, which has continued into the second half of the year. It expects new business profit to grow in all of 2024 in line with its objective for 2022-27 of a 15% to 20% compound annual growth rate.
CitiGroup raises Direct Line Group to Buy from Neutral (7 Buy, 10 Hold, 0 Sell)
UK
Hochschild Mining
Prudential
Puretech Health
US
CrowdStrike Holdings
HP
NVIDIA
Salesforce
UK
Grafton Group
Hunting
PPHE Hotel Group
US
Lululemon Athletica
MongoDB
Fed’s Bostic speech
UK 100 companies going ex-dividend on 29th August 2024:
Diageo
LondonMetric Property
Glencore
Auto Trader Group
InterContinental Hotels Group
UK 250 companies going ex-dividend on 22nd August 2024:
Diversified Energy Company
Dr. Martens
JPMorgan Global Growth & Income
ZIGUP
RHI Magnesita N.V.
Alliance Trust
Centamin
Serco Group
Henderson Smaller Cos Inv Tst
Clarkson
Quilter
PageGroup
Savills
Genuit Group
Dowlais Group
JPMorgan American Investment Trust
Plus500
Bluefield Solar Income Fund
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.